The global chlamydia diagnosis and treatment market is anticipated to grow at a considerable CAGR of 6.0% during the forecast period (2021-2027). The rising pervasiveness of chlamydia trachomatis disease is one of the prime factors affecting and driving the market. According to U.S. Department of Health & Human Services, chlamydia is considered to be one of the common sexually transmitted infections in the US that is affecting around 2.86 million infections every year.
Browse the full report description of "Global Chlamydia Diagnosis and Treatment Market Research By Diagnosis Methods (Chlamydia Culture, Urine Culture, Enzyme Immunoassays and Nucleic Acid Amplification Test), By Treatment Approach (Oral Antibiotics and Injectable), and By End-User (Hospitals, Diagnostic Centers And Research Institutions) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/chlamydia-diagnosis-treatment-market
The key players operating in the global chlamydia diagnosis and treatment market had been adopting strategy to gain major market share. For instance, in March 2021, Binx health had received approval from the US Food and Drug Administration (FDA) for Clinical Laboratory Improvement Amendments (CLIA) waiver. CLIA is considered to be the molecular point of care testing platform for diagnosis of chlamydia (CT) and gonorrhea (NG) which, will give result in around 30 minutes of time.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Diagnosis Methods
o By Treatment Approach
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Chlamydia Diagnosis and Treatment Market - Segmentation
By Diagnosis Methods
• Chlamydia Culture
• Urine Culture
• Enzyme Immunoassays
• Nucleic Acid Amplification Test
By Treatment Approach
• Oral Antibiotics
• Injectable
By End-User
• Hospitals
• Diagnostic Centers
• Research Institutions
Global Chlamydia Diagnosis and Treatment Market by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/chlamydia-diagnosis-treatment-market